首页|多巴胺、呋塞米联合硝酸甘油治疗风湿性心脏病心力衰竭的临床疗效研究

多巴胺、呋塞米联合硝酸甘油治疗风湿性心脏病心力衰竭的临床疗效研究

扫码查看
目的 分析风湿性心脏病心力衰竭患者使用多巴胺、呋塞米、硝酸甘油联合治疗方案所取得的效果.方法 140 例风湿性心脏病心力衰竭患者作为研究对象,按照随机数字表法分为对照组和观察组,各 70 例.对照组患者接受多巴胺治疗,观察组患者接受多巴胺联合呋塞米、硝酸甘油治疗.对比两组临床疗效,心功能指标,不良反应发生率,治疗前后脑钠肽水平、6 min步行距离.结果 观察组临床总有效率为 95.71%,高于对照组的 81.43%(P<0.05).治疗前,两组左心室射血分数(LVEF)、左室收缩末期内径(LVESD)、左室舒张末期内径(LVEDD)对比无差异(P>0.05);治疗后,两组LVEF均得到显著提升,LVEDD以及LVESD均得到显著降低,且观察组LVEF(39.38±3.76)%、LVEDD(61.02±5.92)mm、LVESD(45.47±4.29)mm均明显优于对照组的(35.24±3.31)%、(66.39±6.48)mm、(51.03±4.88)mm(P<0.05).观察组的不良反应发生率 10.00%与对照组的 7.14%对比无差异(P>0.05).治疗前,两组的脑钠肽水平、6 min步行距离对比无差异(P>0.05);治疗后,两组的脑钠肽水平、6 min步行距离均优于治疗前,且观察组脑钠肽(762.72±58.54)ng/L、6 min步行距离(363.24±25.27)m优于对照组的(953.48±71.06)ng/L、(310.27±22.31)m(P<0.05).结论 风湿性心脏病心力衰竭患者接受多巴胺联合呋塞米、硝酸甘油治疗,患者的心脏功能明显提升,脑钠肽水平明显降低,体能明显提升,具有较高的治疗效果,并且在治疗期间无明显的不良反应.
Study on clinical efficacy of combining dopamine,furosemide and nitroglycerin in patients with rheumatic heart disease and heart failure
Objective To analyze the effect of combining dopamine,furosemide and nitroglycerin in patients with rheumatic heart disease and heart failure.Methods 140 patients with rheumatic heart disease and heart failure were divided into a control group and an observation group according to random number table method,each with 70 cases.The control group was treated with dopamine,and the observation group was treated with dopamine combined with furosemide and nitroglycerin.The clinical efficacy,cardiac function index,incidence of adverse reactions,brain natriuretic peptide level and 6-min walking distance before and after treatment were compared between the two groups.Results The total effective rate of the observation group was 95.71%,which was higher than the control group's 81.43%(P<0.05).Before treatment,there was no differences in left ventricular ejection fraction(LVEF),left ventricular end-systolic diameter(LVESD)and left ventricular end-diastolic diameter(LVEDD)between the two groups(P>0.05).After treatment,LVEF was significantly increased,and LVEDD and LVESD were significantly decreased in both groups;the observation group had LVEF of(39.38±3.76)%,LVEDD of(61.02±5.92)mm and LVESD of(45.47±4.29)mm,which were significantly better than(35.24±3.31)%,(66.39±6.48)mm and(51.03±4.88)mm in the control group(P<0.05).The incidence of adverse reactions in the observation group was 10.00%,which was not different from 7.14%in the control group(P>0.05).Before treatment,there was no difference in brain natriuretic peptide level and 6-min walking distance between the two groups(P>0.05).After treatment,the brain natriuretic peptide level and 6-min walking distance in both groups were better than those before treatment;the observation group had brain natriuretic peptide of(762.72±58.54)ng/L and 6-min walking distance of(363.24±25.27)m,which were better than(953.48±71.06)ng/L and(310.27±22.31)m in the control group(P<0.05).Conclusion Combining dopamine and furosemide and nitroglycerin has a high therapeutic effect on patients with rheumatic heart disease and heart failure,which can significantly improve their heart function,lower the level of brain natriuretic peptide,and improve the physical ability,and there are no obvious adverse reactions during the treatment.

Rheumatic heart diseaseHeart failureDopamineFurosemideNitroglycerin

姚周伟

展开 >

276400 临沂市中心医院

风湿性心脏病 心力衰竭 多巴胺 呋塞米 硝酸甘油

2024

中国实用医药
中国康复医学会

中国实用医药

影响因子:0.797
ISSN:1673-7555
年,卷(期):2024.19(12)